Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, whento
Search This Board: 
Last Post: 8/22/2017 4:12:53 PM - Followers: 448 - Board type: Free - Posts Today: 90



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#53730  Sticky Note For those who are new to the board: UndervaluedStocks 08/20/17 10:21:13 PM
#49456  Sticky Note Attention all new investors in ARYC!! whento 07/12/17 10:40:46 PM
#47743  Sticky Note Ladies and Gentlemen, as incredulous as it may spotlight1 06/29/17 01:44:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#53924   Sounds good . Hope you get filled with whento 08/22/17 04:12:53 PM
#53923   Just got more cap to buy more tomorrow Cayman75 08/22/17 04:09:34 PM
#53922   And are getting them. whento 08/22/17 03:54:29 PM
#53921   Someone is trying to get as many cheap Cayman75 08/22/17 03:52:24 PM
#53920   well someone felt it worthwhile to invest 10gs. whento 08/22/17 03:50:58 PM
#53919   I have to say MM games here. All whento 08/22/17 03:40:23 PM
#53918   No problem. Patience will pay off imo. Marking whento 08/22/17 03:12:47 PM
#53917   ARYC$$ Meq 08/22/17 03:12:18 PM
#53916   I've had enough of this keyboard arguing for Doc Hollywood 08/22/17 02:52:04 PM
#53914   Well said, my all pessimistics, sell and HighYieldStocks 08/22/17 02:47:51 PM
#53913   Yes I would still buy. I don't look techmover 08/22/17 02:45:42 PM
#53910   As I said Hugie I am not happy Doc Hollywood 08/22/17 02:32:26 PM
#53909   Did not you think about that this negativity Hugie 08/22/17 02:28:03 PM
#53908   Some of the older posters here will tell Doc Hollywood 08/22/17 02:27:37 PM
#53906   Somebody needs to personally visit company and see digitalnilesh 08/22/17 02:24:20 PM
#53905   I can't disagree with you more! Doc Hollywood 08/22/17 02:21:14 PM
#53904   I doubt very much that ideas and speculations jrsh 08/22/17 02:18:40 PM
#53903   Another old wives tale. rh22 08/22/17 02:13:12 PM
#53902   Yesterday we were way UP and today way Alyssa 08/22/17 02:12:19 PM
#53900   I am not posting my point of view rh22 08/22/17 02:01:41 PM
#53898   Well Said Alyssa. LOL whento 08/22/17 01:58:24 PM
#53897   I Agree Alyssa, don't let anyone shake your Penny Traders Club 08/22/17 01:52:18 PM
#53896   Who honestly would care about such a thing? Alyssa 08/22/17 01:52:05 PM
#53895   It really doesn't matter MikeCR. The tweets are Doc Hollywood 08/22/17 01:50:56 PM
#53893   Just posting the customers websites won't copy the MikeCr 08/22/17 01:47:22 PM
#53892   Just to keep everybody updated: rh22 08/22/17 01:46:19 PM
#53891   NEW tweet...Arrayit microarray platform customers at the Slovak HighYieldStocks 08/22/17 01:35:10 PM
#53890   NEW tweet...Arrayit reports microarray instrument inquiry from adv HighYieldStocks 08/22/17 01:34:58 PM
#53889   NEW tweet...Arrayit senior scientists invited to Applied Pharmaceu HighYieldStocks 08/22/17 01:34:49 PM
#53888   Every single customer or company for years has Doc Hollywood 08/22/17 01:31:13 PM
#53887   YOU CANNOT KNOW WHAT YOU OWN BECAUSE NO rh22 08/22/17 01:29:46 PM
#53886   Also a great day for someone to add bz777 08/22/17 01:26:48 PM
#53884   It would be a great day for someone bz777 08/22/17 01:26:18 PM
#53882   Those big companies do not have any idea Hugie 08/22/17 01:23:42 PM
#53881   Speaking of delinquent financials, WHERE ARE THEY? rh22 08/22/17 01:20:53 PM
#53880   It is illegal to post fake tweets. They Doc Hollywood 08/22/17 01:19:59 PM
#53879   The price will not revisit the 00 depths rh22 08/22/17 01:16:58 PM
#53878   Buyers beginning to take the sellers shares at .01 Doc Hollywood 08/22/17 01:16:42 PM
#53877   If the company has not been sending those Hugie 08/22/17 01:16:18 PM
#53876   rh22, you missed his/her point "Remember, this is glory2000 08/22/17 01:16:17 PM
#53875   Okay then, you seem to agree that it Doc Hollywood 08/22/17 01:08:16 PM
#53874   I posted yesterday that ARYC's pps share is rh22 08/22/17 01:06:15 PM
#53873   Well there is that 1.7 million share seller Doc Hollywood 08/22/17 01:06:08 PM
#53872   Some people earn money on flipping this stock. Hugie 08/22/17 01:05:22 PM
#53871   Okay, since most otc stocks have absolutely no Doc Hollywood 08/22/17 01:03:14 PM
#53870   Yup the selling continues unabated and very stealthly. rh22 08/22/17 01:02:11 PM
#53869   This is what I am saying.We do not Hugie 08/22/17 01:01:18 PM
#53868   Some back of the envelope calculations: rh22 08/22/17 12:58:07 PM
#53867   Don't know if that big seller is still Doc Hollywood 08/22/17 12:56:58 PM
#53866   This list basically proves what a lot of rh22 08/22/17 12:49:06 PM